Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058051HIVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057150HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057354HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20040604HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS44006680HTLV-1ENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TCGA Plot Options
Drug Information
GeneDRD3
DrugBank IDDB00589
Drug NameLisuride
Target IDBE0000581
UniProt IDP35462
Regulation Typeagonist
PubMed IDs18691132
CitationsKvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67.
GroupsApproved; Investigational
Direct ClassificationIndoloquinolines
SMILES[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC
Pathways
PharmGKBPA164749019
ChEMBLCHEMBL157138